VIAF

Virtual International Authority File

Search

Leader 00000nz a2200037n 45 0
001 WKP|Q55232832 (VIAF cluster) (Authority/Source Record)
003 WKP
005 20241121000142.0
008 241121nneanz||abbn n and d
035 ‎‡a (WKP)Q55232832‏
024 ‎‡a 0000-0002-5902-2568‏ ‎‡2 orcid‏
024 ‎‡a 56248497200‏ ‎‡2 scopus‏
035 ‎‡a (OCoLC)Q55232832‏
100 0 ‎‡a Giuseppe Rossi‏ ‎‡c researcher ORCID: 0000-0002-5902-2568‏ ‎‡9 en‏
375 ‎‡a 1‏ ‎‡2 iso5218‏
400 0 ‎‡a Giuseppe Rossi‏ ‎‡c onderzoeker‏ ‎‡9 nl‏
670 ‎‡a Author's A genome-wide investigation of SNPs and CNVs in schizophrenia‏
670 ‎‡a Author's Alexithymia in healthy women: a brain morphology study‏
670 ‎‡a Author's Association between IL-1beta -511C/T and IL-1RA (86bp)n repeats polymorphisms and schizophrenia‏
670 ‎‡a Author's Burnout in Nonhospital Psychiatric Residential Facilities‏
670 ‎‡a Author's Clinical characteristics in long-term care psychiatric patients: a descriptive study‏
670 ‎‡a Author's Depression prevention and mental health promotion interventions: is stigma taken into account? An overview of the Italian initiatives‏
670 ‎‡a Author's Drug dose as mediator of treatment effect in antidepressant drug trials: the case of fluoxetine‏
670 ‎‡a Author's Erratum to: Long-acting antipsychotic drugs for the treatment of schizophrenia: use in daily practice from naturalistic observations‏
670 ‎‡a Author's Further evidence on the lack of association between glycogen synthase kinase 3?? gene polymorphisms and bipolar disorder‏
670 ‎‡a Author's -G308A tumor necrosis factor alpha functional polymorphism and schizophrenia risk: meta-analysis plus association study.‏
670 ‎‡a Author's Long-acting antipsychotic drugs for the treatment of schizophrenia: use in daily practice from naturalistic observations‏
670 ‎‡a Author's Outcome assessment of the VADO approach in psychiatric rehabilitation: a partially randomised multicentric trial‏
670 ‎‡a Author's Rationale and design of an independent randomised controlled trial evaluating the effectiveness of aripiprazole or haloperidol in combination with clozapine for treatment-resistant schizophrenia‏
670 ‎‡a Author's Self-stigma as a mediator between social capital and empowerment among people with major depressive disorder in Europe: the ASPEN study‏
670 ‎‡a Author's Structural brain features of borderline personality and bipolar disorders‏
670 ‎‡a Author's The effect of service satisfaction and spiritual well-being on the quality of life of patients with schizophrenia‏
670 ‎‡a Author's The stigma of schizophrenia from patients' and relatives' view: A pilot study in an Italian rehabilitation residential care unit‏
670 ‎‡a Author's Violent behavior of patients living in psychiatric residential facilities: a comparison of male patients with different violence histories‏
670 ‎‡a Author's Volumetric and topographic differences in hippocampal subdivisions in borderline personality and bipolar disorders‏
670 ‎‡a Author's Whole-brain microstructural white matter alterations in borderline personality disorder patients‏
909 ‎‡a (scopus) 56248497200‏ ‎‡9 1‏
909 ‎‡a (orcid) 0000000259022568‏ ‎‡9 1‏
919 ‎‡a depressionpreventionandmentalhealthpromotioninterventionsisstigmatakenintoaccountanoverviewoftheitalianinitiatives‏ ‎‡A Depression prevention and mental health promotion interventions: is stigma taken into account? An overview of the Italian initiatives‏ ‎‡9 1‏
919 ‎‡a clinicalcharacteristicsinlongtermcarepsychiatricpatientsadescriptivestudy‏ ‎‡A Clinical characteristics in long-term care psychiatric patients: a descriptive study‏ ‎‡9 1‏
919 ‎‡a burnoutinnonhospitalpsychiatricresidentialfacilities‏ ‎‡A Burnout in Nonhospital Psychiatric Residential Facilities‏ ‎‡9 1‏
919 ‎‡a associationbetweenil1beta511ctandil1ra86bpnrepeatspolymorphismsandschizophrenia‏ ‎‡A Association between IL-1beta -511C/T and IL-1RA (86bp)n repeats polymorphisms and schizophrenia‏ ‎‡9 1‏
919 ‎‡a alexithymiainhealthywomenabrainmorphologystudy‏ ‎‡A Alexithymia in healthy women: a brain morphology study‏ ‎‡9 1‏
919 ‎‡a genomewideinvestigationofsnpsandcnvsinschizophrenia‏ ‎‡A A genome-wide investigation of SNPs and CNVs in schizophrenia‏ ‎‡9 1‏
919 ‎‡a wholebrainmicrostructuralwhitematteralterationsinborderlinepersonalitydisorderpatients‏ ‎‡A Whole-brain microstructural white matter alterations in borderline personality disorder patients‏ ‎‡9 1‏
919 ‎‡a volumetricandtopographicdifferencesinhippocampalsubdivisionsinborderlinepersonalityandbipolardisorders‏ ‎‡A Volumetric and topographic differences in hippocampal subdivisions in borderline personality and bipolar disorders‏ ‎‡9 1‏
919 ‎‡a violentbehaviorofpatientslivinginpsychiatricresidentialfacilitiesacomparisonofmalepatientswithdifferentviolencehistories‏ ‎‡A Violent behavior of patients living in psychiatric residential facilities: a comparison of male patients with different violence histories‏ ‎‡9 1‏
919 ‎‡a stigmaofschizophreniafrompatientsandrelativesviewapilotstudyinanitalianrehabilitationresidentialcareunit‏ ‎‡A The stigma of schizophrenia from patients' and relatives' view: A pilot study in an Italian rehabilitation residential care unit‏ ‎‡9 1‏
919 ‎‡a effectofservicesatisfactionandspiritualwellbeingonthequalityoflifeofpatientswithschizophrenia‏ ‎‡A The effect of service satisfaction and spiritual well-being on the quality of life of patients with schizophrenia‏ ‎‡9 1‏
919 ‎‡a structuralbrainfeaturesofborderlinepersonalityandbipolardisorders‏ ‎‡A Structural brain features of borderline personality and bipolar disorders‏ ‎‡9 1‏
919 ‎‡a selfstigmaasamediatorbetweensocialcapitalandempowermentamongpeoplewithmajordepressivedisorderineuropetheaspenstudy‏ ‎‡A Self-stigma as a mediator between social capital and empowerment among people with major depressive disorder in Europe: the ASPEN study‏ ‎‡9 1‏
919 ‎‡a rationaleanddesignofanindependentrandomisedcontrolledtrialevaluatingtheeffectivenessofaripiprazoleorhaloperidolincombinationwithclozapinefortreatmentresistantschizophrenia‏ ‎‡A Rationale and design of an independent randomised controlled trial evaluating the effectiveness of aripiprazole or haloperidol in combination with clozapine for treatment-resistant schizophrenia‏ ‎‡9 1‏
919 ‎‡a outcomeassessmentofthevadoapproachinpsychiatricrehabilitationapartiallyrandomisedmulticentrictrial‏ ‎‡A Outcome assessment of the VADO approach in psychiatric rehabilitation: a partially randomised multicentric trial‏ ‎‡9 1‏
919 ‎‡a longactingantipsychoticdrugsforthetreatmentofschizophreniauseindailypracticefromnaturalisticobservations‏ ‎‡A Long-acting antipsychotic drugs for the treatment of schizophrenia: use in daily practice from naturalistic observations‏ ‎‡9 1‏
919 ‎‡a g308atumornecrosisfactoralphafunctionalpolymorphismandschizophreniariskmetaanalysisplusassociationstudy‏ ‎‡A -G308A tumor necrosis factor alpha functional polymorphism and schizophrenia risk: meta-analysis plus association study.‏ ‎‡9 1‏
919 ‎‡a furtherevidenceonthelackofassociationbetweenglycogensynthasekinase3genepolymorphismsandbipolardisorder‏ ‎‡A Further evidence on the lack of association between glycogen synthase kinase 3?? gene polymorphisms and bipolar disorder‏ ‎‡9 1‏
919 ‎‡a erratumtolongactingantipsychoticdrugsforthetreatmentofschizophreniauseindailypracticefromnaturalisticobservations‏ ‎‡A Erratum to: Long-acting antipsychotic drugs for the treatment of schizophrenia: use in daily practice from naturalistic observations‏ ‎‡9 1‏
919 ‎‡a drugdoseasmediatoroftreatmenteffectinantidepressantdrugtrialsthecaseoffluoxetine‏ ‎‡A Drug dose as mediator of treatment effect in antidepressant drug trials: the case of fluoxetine‏ ‎‡9 1‏
946 ‎‡a b‏ ‎‡9 1‏
996 ‎‡2 NUKAT|n 2021091807
996 ‎‡2 NSK|000489202
996 ‎‡2 ISNI|0000000403632230
996 ‎‡2 DNB|104054123
996 ‎‡2 DNB|1316127893
996 ‎‡2 JPG|500353873
996 ‎‡2 J9U|987007367008005171
996 ‎‡2 DNB|1164194348
996 ‎‡2 ISNI|0000000070201677
996 ‎‡2 BAV|495_9363
996 ‎‡2 BAV|495_226
996 ‎‡2 BAV|495_227
996 ‎‡2 NSK|000389348
996 ‎‡2 BAV|495_225
996 ‎‡2 SUDOC|220437815
996 ‎‡2 PTBNP|157830
996 ‎‡2 BNF|15404718
996 ‎‡2 DE633|pe30008675
996 ‎‡2 BNF|12229396
996 ‎‡2 LC|n 95026149
996 ‎‡2 BNF|10741229
996 ‎‡2 BAV|495_247127
996 ‎‡2 BNF|12345504
996 ‎‡2 SUDOC|03513433X
996 ‎‡2 SUDOC|22658416X
996 ‎‡2 LC|n 85830066
996 ‎‡2 ISNI|0000000108963678
996 ‎‡2 ICCU|BVEV050444
996 ‎‡2 DNB|117742996
996 ‎‡2 BAV|495_299409
996 ‎‡2 ISNI|0000000456558054
996 ‎‡2 LC|nb2014027927
996 ‎‡2 DE633|pe30015648
996 ‎‡2 LC|n 2010182167
996 ‎‡2 LC|n 87864781
996 ‎‡2 ISNI|0000000072500881
996 ‎‡2 BIBSYS|90279479
996 ‎‡2 CAOONL|ncf11258382
996 ‎‡2 DNB|137069383
996 ‎‡2 RERO|A024110937
996 ‎‡2 ISNI|0000000061438576
996 ‎‡2 BNC|981058509437806706
996 ‎‡2 BNF|11972966
996 ‎‡2 ICCU|CFIV044168
996 ‎‡2 BAV|495_222
996 ‎‡2 NUKAT|n 2012045868
996 ‎‡2 BAV|495_381747
996 ‎‡2 BNF|12453947
996 ‎‡2 BAV|495_100900
996 ‎‡2 BNF|14604750
996 ‎‡2 SUDOC|268688117
996 ‎‡2 RERO|A017390162
996 ‎‡2 BNE|XX1532752
996 ‎‡2 DNB|124095968
996 ‎‡2 ISNI|0000000388981423
996 ‎‡2 DNB|132396408
996 ‎‡2 DNB|137867301
996 ‎‡2 ISNI|0000000052256041
996 ‎‡2 BAV|495_54804
996 ‎‡2 SUDOC|183431855
996 ‎‡2 BAV|495_54800
996 ‎‡2 BAV|495_246975
996 ‎‡2 BAV|495_246974
996 ‎‡2 BAV|495_246976
996 ‎‡2 BNE|XX1537975
996 ‎‡2 ISNI|0000000051670072
996 ‎‡2 BAV|495_246973
996 ‎‡2 BAV|495_246972
996 ‎‡2 LC|no2008079386
996 ‎‡2 RERO|A008616656
996 ‎‡2 SUDOC|11048374X
996 ‎‡2 NTA|236441175
996 ‎‡2 BAV|495_9368
996 ‎‡2 NKC|xx0216563
996 ‎‡2 ISNI|000000005161947X
996 ‎‡2 DNB|1028534205
996 ‎‡2 LC|n 88274533
996 ‎‡2 NSK|000384885
996 ‎‡2 BNE|XX4828294
996 ‎‡2 BAV|495_178813
996 ‎‡2 DNB|136421717
996 ‎‡2 NSK|000533306
996 ‎‡2 SUDOC|157559289
996 ‎‡2 DNB|124884016
996 ‎‡2 DE633|pe40219865
996 ‎‡2 BAV|495_88415
996 ‎‡2 CAOONL|ncf13709337
996 ‎‡2 NII|DA05185912
996 ‎‡2 DNB|119031760
996 ‎‡2 SUDOC|198609752
996 ‎‡2 PLWABN|9810553480305606
996 ‎‡2 PLWABN|9810629653505606
996 ‎‡2 ISNI|0000000121264935
996 ‎‡2 JPG|500022119
996 ‎‡2 SUDOC|069781850
996 ‎‡2 DNB|139588426
996 ‎‡2 DNB|1054661847
996 ‎‡2 BNE|XX1766667
996 ‎‡2 SUDOC|164496025
996 ‎‡2 DNB|129680680
996 ‎‡2 LC|n 80045554
996 ‎‡2 ISNI|0000000067071314
996 ‎‡2 SUDOC|203546040
996 ‎‡2 ISNI|0000000081725572
996 ‎‡2 SUDOC|074152327
996 ‎‡2 BAV|495_274307
996 ‎‡2 DNB|1089682530
996 ‎‡2 LC|n 91017382
996 ‎‡2 LC|n 2018182219
996 ‎‡2 ICCU|RAVV073061
996 ‎‡2 LC|n 2003078734
996 ‎‡2 NTA|067713521
996 ‎‡2 ISNI|0000000114497925
996 ‎‡2 BIBSYS|1048515
996 ‎‡2 NUKAT|n 2018167425
996 ‎‡2 DNB|1205982418
996 ‎‡2 JPG|500007493
996 ‎‡2 BIBSYS|1095499
996 ‎‡2 BNF|13483073
996 ‎‡2 ICCU|CUBV170046
996 ‎‡2 DNB|1011751631
996 ‎‡2 J9U|987007384136605171
996 ‎‡2 ISNI|0000000068106937
996 ‎‡2 PTBNP|1303689
996 ‎‡2 RERO|A023147795
996 ‎‡2 DE633|pe50049085
996 ‎‡2 CAOONL|ncf11565119
996 ‎‡2 DE633|pe40215118
996 ‎‡2 BAV|495_39257
996 ‎‡2 SUDOC|113851375
996 ‎‡2 NUKAT|n 2004076209
996 ‎‡2 ICCU|MUSV056884
996 ‎‡2 BNF|10745621
996 ‎‡2 LIH|LNB:C8PI;=BA
996 ‎‡2 JPG|500007901
996 ‎‡2 RERO|A020358817
996 ‎‡2 LIH|LNB:BCVC;=_w_3
996 ‎‡2 DNB|100051278
996 ‎‡2 ISNI|0000000446179990
996 ‎‡2 ISNI|0000000025127033
996 ‎‡2 NSK|000253797
996 ‎‡2 DNB|104276770
996 ‎‡2 BAV|495_57197
996 ‎‡2 LIH|LNB:J_h__a_;=B_j_
996 ‎‡2 BIBSYS|90729929
996 ‎‡2 DE633|pe40218757
996 ‎‡2 LC|n 98044537
996 ‎‡2 DNB|1329677358
996 ‎‡2 J9U|987007275867405171
996 ‎‡2 NTA|06916424X
996 ‎‡2 BAV|495_350137
996 ‎‡2 BNC|981060732321906706
996 ‎‡2 ICCU|CUBV137108
996 ‎‡2 ISNI|0000000454570666
996 ‎‡2 BAV|495_244777
996 ‎‡2 BAV|495_127783
996 ‎‡2 PLWABN|9810547005005606
996 ‎‡2 LIH|LNB:,3_t_;=BY
996 ‎‡2 BAV|495_150555
996 ‎‡2 BLBNB|001273298
996 ‎‡2 SUDOC|143286250
996 ‎‡2 BNF|16997576
996 ‎‡2 DNB|1037604547
996 ‎‡2 RERO|A018841403
996 ‎‡2 NUKAT|n 2004032695
996 ‎‡2 LC|no 00009072
996 ‎‡2 RERO|A003762069
996 ‎‡2 ISNI|0000000024287596
996 ‎‡2 SUDOC|158329325
996 ‎‡2 DNB|115767495X
996 ‎‡2 LC|n 2022000162
996 ‎‡2 J9U|987007462080005171
996 ‎‡2 BAV|495_344531
996 ‎‡2 J9U|987007267195505171
996 ‎‡2 BAV|495_14765
996 ‎‡2 BAV|495_3925
996 ‎‡2 NTA|07122730X
996 ‎‡2 ICCU|TO0V477784
996 ‎‡2 SUDOC|251040062
996 ‎‡2 BLBNB|001492841
996 ‎‡2 ISNI|0000000028426258
996 ‎‡2 PLWABN|9810622871205606
996 ‎‡2 DNB|104054182
996 ‎‡2 SUDOC|059205946
996 ‎‡2 RERO|A003762189
996 ‎‡2 RERO|A012365415
996 ‎‡2 SUDOC|262264552
996 ‎‡2 NKC|mzk2009533749
996 ‎‡2 DE633|pe30006929
996 ‎‡2 LC|no2024070959
996 ‎‡2 ICCU|CFIV023743
996 ‎‡2 JPG|500055424
996 ‎‡2 BAV|495_295010
996 ‎‡2 DE633|pe30011433
996 ‎‡2 BAV|495_228816
996 ‎‡2 BNF|15007386
996 ‎‡2 BAV|495_40292
996 ‎‡2 BAV|495_40294
996 ‎‡2 NTA|070656509
996 ‎‡2 ICCU|CUBV170161
996 ‎‡2 BAV|495_333001
996 ‎‡2 ICCU|CFIV228475
996 ‎‡2 BNF|12112085
996 ‎‡2 ISNI|0000000088258057
996 ‎‡2 SUDOC|06077911X
996 ‎‡2 DNB|1037570634
996 ‎‡2 SUDOC|034615393
996 ‎‡2 DNB|1312049758
996 ‎‡2 BNF|12388842
996 ‎‡2 CAOONL|ncf11490422
996 ‎‡2 ICCU|SBLV201574
996 ‎‡2 NTA|069201692
996 ‎‡2 DNB|120051338
996 ‎‡2 SUDOC|085975664
996 ‎‡2 NTA|15314940X
996 ‎‡2 LC|no2015031095
996 ‎‡2 BNC|981058509975206706
996 ‎‡2 LC|nb2016015623
996 ‎‡2 DNB|1157517420
996 ‎‡2 DNB|100257712
996 ‎‡2 BNF|14969130
996 ‎‡2 LC|no2010017888
996 ‎‡2 PLWABN|9812829795405606
996 ‎‡2 RERO|A003762192
996 ‎‡2 DE633|pe30021526
996 ‎‡2 DE633|pe40215123
996 ‎‡2 ISNI|0000000061439341
996 ‎‡2 ISNI|0000000360873359
996 ‎‡2 BAV|495_78179
996 ‎‡2 SUDOC|235370975
996 ‎‡2 NYNYRILM|16051
996 ‎‡2 BNE|XX1749640
996 ‎‡2 LC|n 85064422
996 ‎‡2 BAV|495_373554
996 ‎‡2 ISNI|0000000066332295
996 ‎‡2 BNF|14976719
996 ‎‡2 BAV|495_43444
996 ‎‡2 ISNI|0000000058901769
996 ‎‡2 BAV|495_151310
996 ‎‡2 DNB|1229178600
996 ‎‡2 BAV|495_100913
996 ‎‡2 SUDOC|250140330
996 ‎‡2 BNC|981058526534206706
996 ‎‡2 J9U|987007260248705171
996 ‎‡2 BIBSYS|3106540
996 ‎‡2 DNB|1037620917
996 ‎‡2 LC|n 85224810
996 ‎‡2 NUKAT|n 2014053028
996 ‎‡2 SUDOC|273468553
996 ‎‡2 DNB|119120852
997 ‎‡a 0 0 lived 0 0‏ ‎‡9 1‏